companydata.dkcompanydata.dk

GXP PHARMAID ApS: Financial statements 2021

CVR: 29615861

Source: annual report 2021, Danish Business Authority

01/01/2021 – 31/12/2021

GXP PHARMAID ApS (CVR 29615861) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK 363,324 and a net result of DKK -503,961 compared with DKK 960,283 the year before. That is a decrease of 87% compared with the year before. Equity in the 2021 report amounted to DKK 691,287. The solvency ratio was 67.1%. The company had 2 employees in the financial year.

Gross Profit
DKK 363,324
Profit/Loss
DKK -503,961
Equity
DKK 691,287
Total Assets
DKK 1,030,858
Employees
2

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2021-363 t.-504 t.691 t.2
2020-2.8 mio.960 t.1.7 mio.3
2019-763 t.-169 t.735 t.1
2018-1.1 mio.217 t.904 t.1
2017-1.4 mio.142 t.687 t.1

Official annual report

View the official annual report directly on the page with a Pro subscription.

Find more companies like GXP PHARMAID ApS

Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.

Try the lead list generator

Events in 2021

GXP PHARMAID ApS: The 2020 annual report is outJun 21, 2021

GXP PHARMAID ApS has published its annual report for 2020. Gross profit came to DKK 2,798,982, and the net result was DKK 960,283.

About GXP PHARMAID ApS

GXP PHARMAID ApS is a Danish company of the type Anpartsselskab based in Brønshøj, founded in 2006. The company is registered under the industry Anden teknisk rådgivning. The company was previously named Q-VIGILANCE ApS. The management consists of Nusret Asanovski. The company is owned by MAC ANDORBY ApS. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK 1,163,256 and a net result of DKK 122,320 compared with DKK 216,532 the year before. Equity in the 2025 report amounted to DKK 1,218,531.

Source: annual report 2025, Danish Business Authority